当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:105.34亿  总市值:105.34亿
流通股本:3.18亿   总股本:3.18亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.47亿元,每股收益0.45元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益455837.05万元,未分配利润205560.64万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产561207.96万元,负债105370.91万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,195,500,051.78688,989,400.72,283,832,911.431,782,020,224.83
营业总成本1,066,058,361.3575,353,290.721,941,857,521.471,468,536,204.53
其他经营收益
营业利润157,537,694.29126,546,211.91401,827,808.74340,804,804.26
利润总额156,193,043.7125,489,878.45401,956,704.73342,418,496.53
净利润147,213,041.4116,197,969.19381,008,045.8318,977,945.89
每股收益
其他综合收益625,201.66457,278.77-13,065,819.88-23,664,262.3
综合收益总额147,838,243.06116,655,247.96367,942,225.92295,313,683.59
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,607,094,479.982,863,421,109.962,652,447,941.352,660,812,428.8
非流动资产:
非流动资产合计3,004,985,131.762,967,019,491.483,135,020,853.662,980,882,308.02
资产总计5,612,079,611.745,830,440,601.445,787,468,795.015,641,694,736.82
流动负债:
流动负债合计897,276,443.44966,907,036.971,022,403,542.51948,841,682.54
非流动负债:
非流动负债合计156,432,636.53154,732,287.72146,929,219.71151,377,325.7
负债合计1,053,709,079.971,121,639,324.691,169,332,762.221,100,219,008.24
所有者权益(或股东权益):
归属于母公司股东权益合计4,307,982,184.484,456,255,374.14,371,550,511.014,301,632,773.15
股东权益合计4,558,370,531.774,708,801,276.754,618,136,032.794,541,475,728.58
负债和股东权益合计5,612,079,611.745,830,440,601.445,787,468,795.015,641,694,736.82
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,199,365,522.61580,704,504.072,429,286,249.011,654,629,831.45
经营活动现金流出小计1,163,725,455.85543,485,302.532,137,619,330.751,540,662,380.11
经营活动产生的现金流量净额35,640,066.7637,219,201.54291,666,918.26113,967,451.34
投资活动产生的现金流量:
投资活动现金流入小计2,293,110,996.441,109,537,955.232,981,647,918.692,056,540,467.27
投资活动现金流出小计2,291,615,423.751,027,103,424.733,772,864,625.612,511,099,207.53
投资活动产生的现金流量净额1,495,572.6982,434,530.5-791,216,706.92-454,558,740.26
筹资活动产生的现金流量:
筹资活动现金流入小计378,868,861.1194,362,611.12193,985,922.810,550,000
筹资活动现金流出小计594,403,076.26212,531,263.4420,813,197.24230,530,706.38
筹资活动产生的现金流量净额-215,534,215.16-18,168,652.28-226,827,274.44-219,980,706.38
汇率变动对现金及现金等价物的影响5,555,997.041,204,511.814,434,529.58962,777.38
现金及现金等价物净增加额-172,842,578.67102,689,591.57-721,942,533.52-559,609,217.92
期末现金及现金等价物余额361,861,452.01637,393,622.25534,704,030.68697,037,346.28
补充资料:
现金及现金等价物的净增加额-172,842,578.67--721,942,533.52-
最新报告期:2025-09-17
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,李婵娟1.331.601.842025-09-17
东海证券杜永宏1.281.511.772025-09-01
TOP↑